TFX Q3 2023 Earnings — Teleflex Incorporated Revenue & Financial Results | Market Cap Arena

TFXTeleflex Incorporated

$5B

Q3 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$746M+8.7% YoY

Gross Profit

$416M55.8% margin

Operating Income

$165M22.1% margin

Net Income

$137M18.4% margin

EPS (Diluted)

$2.90

QoQ Revenue Growth

+0.4%

Cash Flow

Operating Cash Flow

$201M

Free Cash Flow

$177M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$7.5B

Total Liabilities

$3.2B

Stockholders' Equity

$4.3B

Cash & Equivalents

$881M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$746M	$687M	+8.7%
Gross Profit	$416M	$374M	+11.3%
Operating Income	$165M	$132M	+24.8%
Net Income	$137M	$102M	+34.6%

Revenue Segments

Vascular Access

$170M26%

Interventional

$134M20%

Surgical

$113M17%

Anesthesia

$98M15%

Other

$76M11%

Interventional Urology

$74M11%

Geographic Segments

Americas Segment

$428M57%

EMEA

$143M19%

Asia

$93M12%

Oem

$82M11%